Jiaying Mo

Jiaying Mo

Auto-generated profile, based on publicly available information

Jiaying Mo

Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University , Guangzhou

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Stroke
Verified
Journal Article
Closed access
JZJuan Zhu
Juan Zhu
JMJiaying Mo
Jiaying Mo
KLKewei Liu
Kewei Liu
QCQuanfeng Chen
Quanfeng Chen
ZLZheqi Li
Zheqi Li
SPSuyue Pan
Suyue Pan
BACKGROUND: Blood-brain barrier damage has traditionally been considered to determine the occurrence and development of poststroke brain edema, a devastating and life-threatening complication. However, no treatment strategy targeting blood-brain barrier damage has been proven clinically effective in ameliorating brain edema. METHODS: In mice with stroke models induced by transient middle cerebral artery occlusion (MCAO), the changes in glymphatic system (GS) function impairment were detected by ex vivo fluorescence imaging, 2-photon in vivo imaging, and magnetic resonance imaging within 1 week after MCAO, and the effects of GS impairment and recovery on the formation and resolution of brain edema were evaluated. In addition, in patients with ischemic stroke within 1 week after onset, changes in GS function and brain edema were also observed by magnetic resonance imaging. RESULTS: We found that the extravasation of protein-rich fluids into the brain was not temporally correlated with edema formation after MCAO in mice, as brain edema reabsorption preceded blood-brain barrier closure. Strikingly, the time course of edema progression matched well with the GS dysfunction after MCAO. Pharmacological enhancement of the GS function significantly alleviated brain edema developed on day 2 after MCAO, accompanied by less deposition of Aβ (amyloid-β) and better cognitive function. Conversely, functional suppression of the GS delayed the absorption of brain edema on day 7 after MCAO. Moreover, patients with ischemic stroke revealed a consistent trend of GS dysfunction after reperfusion as MCAO mice, which was correlated with the severity of brain edema and functional outcomes. CONCLUSIONS: GS is a key contributor to the formation of brain edema after ischemic stroke, and targeting the GS may be a promising strategy for treating brain edema in ischemic stroke. REGISTRATION: URL: https://www.chictr.org.cn/showproj.html?proj=162857; Unique identifier: NFEC-2019-189.

6 May 2024 in Rheumatology
Verified
Journal Article
Closed access
PDF file
JMJiaying Mo
Jiaying Mo
KHKai Han
Kai Han
KDKan Deng
Kan Deng
WHWenjun Hu
Wenjun Hu
LWLinhui Wang
Linhui Wang
XTXiangliang Tan
Xiangliang Tan
This study aimed to evaluate the activity of the glymphatic system in SLE using a diffusion-based method termed ‘Diffusion Tensor Image Analysis aLong the Perivascular Space (DTI-ALPS)’, and to examine its correlations with morphological changes in the brain. In this cross-sectional study, 45 female patients with SLE and 30 healthy controls (HCs) were included. Voxel-based and surface-based morphometric analyses were performed to examine T1-weighted images, and diffusion tensor images were acquired to determine diffusivity along the x-, y- and z-axes in the plane of the lateral ventricle body. The DTI-ALPS index (ALPS index) was calculated for each patient. The differences in values between patients with SLE and the HC group were compared using the independent samples t test or the Mann–Whitney U test. To determine correlations between the ALPS index and brain morphological parameters, partial correlation analysis and Pearson’s correlation analysis were conducted. Patients with SLE showed lower values for the ALPS index in the left (1.543 ± 0.141 vs 1.713 ± 0.175, P < 0.001), right (1.428 ± 0.142 vs 1.556 ± 0.139, P < 0.001) and whole (1.486 ± 0.121 vs 1.635 ± 0.139, P < 0.001) brain compared with the HC group. Reduced ALPS index showed significant positive correlations with grey matter loss. The non-invasive ALPS index could serve as a sensitive and effective neuroimaging biomarker for individually quantifying glymphatic activity in patients with SLE. Glymphatic system abnormality may be involved in the pathophysiologic mechanism underlying CNS damage in SLE patients.

21 May 2025 in Rheumatology
Verified
Journal Article
Closed access
LWLinhui Wang
Linhui Wang
QHQin Huang
Qin Huang
JWJingyi Wang
Jingyi Wang
FWFuqiang Wu
Fuqiang Wu
WHWenjun Hu
Wenjun Hu
XTXiangliang Tan
Xiangliang Tan
Objectives: Cognitive dysfunction is a common neuropsychiatric manifestation in SLE, particularly affecting processing speed (PS) and memory. This study aims to identify behaviourally relevant topological networks of functional connectivity underlying neuropsychological test performances, using connectome-based predictive modelling (CPM). Methods: Forty-three SLE patients and 34 controls underwent overall cognitive screening, with SLE patients additionally undergoing neurocognitive assessments for PS and memory. Resting-state fMRI was performed to construct functional connectivity matrices. CPM with leave-one-out cross-validation was employed to model the association between functional connectivity and cognitive performances. Linear regression and moderation analyses were employed to identify risk factors for cognitive dysfunction in SLE. Results: CPM models predicted PS and memory scores in SLE in cross-validation, with correlation coefficients (r) between predicted and observed scores ranging from 0.40 to 0.42 (all P < 0.01). Key brain regions contributing to these models commonly included the cingulate cortex, dorsolateral prefrontal cortex, hippocampus, thalamus and cerebellum, which were critical nodes of default mode, frontoparietal and subcortical networks. A combined CPM model incorporating these functional connectomes predicted overall cognitive ability in SLE (r = 0.38, P < 0.05), with no predictive power in controls, confirming specificity. Additionally, higher damage indices were associated with slower PS. Disease activity, daily glucocorticoids dosage and anticardiolipin antibodies levels moderated associations between functional connectivity strength and cognitive performances. Conclusion: CPM identified brain networks that underlie critical cognitive functions in individuals and these neural fingerprints could potentially assist the diagnosis of cognitive dysfunction in SLE.